✨ Health Notices




NEW ZEALAND GAZETTE

20 MAY

1347

Health


Medicines Act 1981

Corrigendum

Consent to the Distribution of a Changed Medicine

In the notice published in the New Zealand Gazette, 29 April 1999, No. 50, page 1185, notice No. 3126, amend the entry for Vastin to show the name and strength in lines 15 and 16 to Fluvastatin sodium equivalent to 20 mg, 40 mg fluvastatin.

Dated this 11th day of May 1999.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

g03594


Corrigendum

Consent to the Distribution of a New Medicine

In the notice published in the New Zealand Gazette, 29 April 1999, No. 50, page 1185, notice No. 3127, the entries in lines 39 to 44 for Macleans Complete Care Coolmint Mouthwash and Macleans Complete Care Freshmint Mouthwash are deleted and the following new notice is substituted:

Consent to the Distribution of New Related Products

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related products set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Cetylpyridinium chloride 0.05% w/w, sodium fluoride 0.05% w/w Mouthwash, solution SmithKline Beecham Consumer Healthcare, Maidenhead, Berkshire, United Kingdom Macleans Complete Care Coolmint Mouthwash
Cetylpyridinium chloride 0.05% w/w, sodium fluoride 0.05% w/w Mouthwash, solution SmithKline Beecham Consumer Healthcare, Maidenhead, Berkshire, United Kingdom Macleans Complete Care Freshmint Mouthwash

Dated this 11th day of May 1999.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

g03593


Consent to the Distribution of a Changed Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Amifostine 500 mg Injection, powder Ben Venue Laboratories Inc., Bedford, Ohio, United States of America; and USB Pharma BV., Nijmegen, The Netherlands Ethyol

Dated this 13th day of May 1999.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

g03596


Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1999, No 56


NZLII PDF NZ Gazette 1999, No 56





✨ LLM interpretation of page content

πŸ₯ Corrigendum for Consent to the Distribution of a Changed Medicine

πŸ₯ Health & Social Welfare
11 May 1999
Corrigendum, Medicines Act 1981, Fluvastatin sodium, Vastin
  • G. R. Boyd, Chief Advisor, Regulation and Safety

πŸ₯ Corrigendum for Consent to the Distribution of a New Medicine

πŸ₯ Health & Social Welfare
11 May 1999
Corrigendum, Medicines Act 1981, Macleans Complete Care Coolmint Mouthwash, Macleans Complete Care Freshmint Mouthwash, Cetylpyridinium chloride, Sodium fluoride
  • G. R. Boyd, Chief Advisor, Regulation and Safety

πŸ₯ Consent to the Distribution of a Changed Medicine

πŸ₯ Health & Social Welfare
13 May 1999
Medicines Act 1981, Amifostine, Ethyol, Injection, Powder
  • G. R. Boyd, Chief Advisor, Regulation and Safety

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
Medicines Act 1981, New Medicines